Budesonide was included in the European Baseline Series in 2000 as the most suitable marker for CS hypersensitivity. In the last 2 decades a decreasing trend of budesonide allergy was observed.

Patch testing of budesonide in Italy: the SIDAPA baseline series experience, 2018-2019

Patruno, Cataldo;
2021-01-01

Abstract

Budesonide was included in the European Baseline Series in 2000 as the most suitable marker for CS hypersensitivity. In the last 2 decades a decreasing trend of budesonide allergy was observed.
2021
Budesonide
SIDAPA baseline series
corticosteroids
patch test
skin tests
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12317/70165
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 11
social impact